Cryptocurrency & Digital Assets

With $16.4M in new funding, STRM.BIO is advancing a novel gene therapy platform that uses natural vesicles to target bone marrow, offering new hope for rare diseases.

A new partnership brings a complex wealth-building insurance product to the digital age, offering instant decisions and no medical exams. Is this the future?

A new tri-specific antibody, IM1240, safely hits cancer cells at massive doses in preclinical studies, potentially solving a key toxicity problem in immunotherapy.

A new joint venture provides crucial short-term loans, aiming to unlock permanent financing for affordable housing projects facing a critical funding gap.

With its revolutionary Prime Editing tech showing promise, Prime Medicine faces a pivotal moment at the J.P. Morgan conference. Can it justify its new strategy?

A Tennessee company's patented 1-to-1 CBD and CBDA formula shows promise in fighting inflammation, setting the stage for a new class of FDA-regulated drugs.

A new blood test in Western Canada promises to detect 59 cancers early. But with a high price tag and pending approval, it raises critical questions.

Evergy is repurchasing $244M of its convertible notes, a strategic play to reduce future stock dilution and manage complex arbitrage market ripples.

Following record financial growth, RadNet promotes four executives to accelerate its shift toward proactive, AI-driven healthcare and expand its market dominance.

Digital banking leader Finshape appoints Neil Budd as CEO, signaling an aggressive global expansion fueled by strategic acquisitions and a focus on AI.

The banking giant's investment in clearinghouse Ubyx signals a major shift towards mainstream adoption of tokenized deposits and stablecoins.

The healthcare virtual assistant market is set to explode, promising radical efficiency but raising critical questions about privacy, bias, and patient trust.

A new multi-target deal combines cutting-edge platforms to create next-gen cancer drugs, aiming to improve precision and patient outcomes.

The Japanese government's 'SUI COLLECTION' is showcasing hidden artisanal treasures to the world, blending tradition with modern luxury in a bold cultural push.

A first-in-class antibody shows a strong safety profile, de-risking development and offering a new, targeted approach for severe autoimmune diseases.

NVIDIA CEO Jensen Huang wins the 2026 IEEE Medal of Honor, a nod to his visionary work that sparked an AI revolution and a $5 trillion empire.

A strategic bet on ethnic grocery-anchored retail pays off as Arc Capital Partners exits a revitalized Torrance center in a $108.5 million blockbuster deal.

Earable Neuroscience partners with Tonino Lamborghini for a $1,999 brainband and joins the NSF's network, betting big on the new market of luxury cognitive tech.

CES 2026 opens with AI dominating everything from PCs to factories, while Las Vegas reaps the rewards of a massive convention center overhaul.

With star hires and proprietary data analytics, Abacus Global Management is making an ambitious play for the booming asset-based finance sector.